Outlook Therapeutics, Inc.
DE ˙ DB
0,75 € ↑0,07 (11,08%)
2026-06-04
PREZZO DELLE AZIONI
SecurityDE:41O / Outlook Therapeutics, Inc.
InstitutionNorthern Trust Corp
Latest Disclosed Ownership67,390 shares
Latest Disclosed Value $ 13,869
Northern Trust Corp ownership in 41O / Outlook Therapeutics, Inc.

On May 14, 2026 - Northern Trust Corp filed a 13F-HR form disclosing ownership of 67,390 shares of Outlook Therapeutics, Inc. (DE:41O) valued at $11,638 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 67,390 shares of Outlook Therapeutics, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $50,677 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F OUTLOOK THERAPEUTICS COM 69012T305 67,390 0 0.00 14 -87.74 0.0000
2026-02-17 2025-12-31 13F OUTLOOK THERAPEUTICS COM 69012T305 67,390 41,321 158.51 106 292.59 0.0000
2025-11-14 2025-09-30 13F OUTLOOK THERAPEUTICS COM 69012T305 26,069 -12,927 -33.15 28 -56.45 0.0000
2025-08-13 2025-06-30 13F OUTLOOK THERAPEUTICS COM 69012T305 38,996 -87,959 -69.28 62 -59.74 0.0000
2025-05-13 2025-03-31 13F OUTLOOK THERAPEUTICS COM 69012T305 126,955 15,205 13.61 155 -27.01 0.0000
2025-02-14 2024-12-31 13F OUTLOOK THERAPEUTICS COM 69012T305 111,750 -7,119 -5.99 211 -66.72 0.0000
2024-11-13 2024-09-30 13F OUTLOOK THERAPEUTICS COM 69012T305 118,869 35,432 42.47 635 3.09 0.0001
2024-08-14 2024-06-30 13F OUTLOOK THERAPEUTICS COM 69012T305 83,437 22,324 36.53 616 -15.64 0.0001
2024-05-14 2024-03-31 13F OUTLOOK THERAPEUTICS COM 69012T305 61,113 61,113 730 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.